Therapeutic interventions in pityriasis rosada: a review of the literature
DOI:
https://doi.org/10.29176/2590843X.125Keywords:
Pityriasis rosea, interventions, bibliographic reviewAbstract
Introduction: Pityriasis rosea is an acute exanthematic eruption; its etiology is associated with the reactivation of herpes virus 6 and 7. The treatment is controversial; several interventions have been suggested seeking to impact on the natural history of the disease.
Objective: To accomplish a systematic review of the literature on available therapies.
Methods: Bibliographic review of publications in Cochrane, Pubmed, Medline, Lilacs and Embase, including randomized controlled studies where therapeutic interventions were evaluated.
Results: Thirteen studies (667 patients) were included, comparing the use of antiviral therapy, antibiotics, systemic steroids and ultraviolet radiation.
Conclusions: We found evidence that allows us to recommend the use of aciclovir to reduce the time of eruption. The use of azithromycin is not recommended. Steroid therapy should be reserved for more severe cases and the use of phototherapy despite having outdated evidence shows favorable data.
Author Biographies
Susana Mejía-Mesa, Universidad Pontificia Bolivariana, Medellín, Colombia
Estudiante, XI semestre, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia
Jorge Hernando Donado-Gómez, Universidad Pontificia Bolivariana, Medellín, Colombia
Médico, epidemiólogo clínico; profesor titular, Universidad Pontificia Bolivariana; Hospital Pablo Tobón Uribe, Medellín, Colombia
Sofía Medina-Escobar, Universidad Pontificia Bolivariana, Medellín, Colombia
Estudiante, XI semestre, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia
References
Wolff K. Fitzpatrick Dermatología en Medicina General. Buenos Aires: Editorial Médica Panamericana; 2009. p. 65-7.
Chuh AA, Dofitas BL, Comisel G, Reveiz L, Sharma V, Garner SE, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007. Fecha de consulta: 16 de abril de 2018. Disponible en: http://doi.wiley.com/10.1002/14651858.CD005068.pub2.
Nair PA, Bhimji SS. Pityriasis rosea. Stat Pearls. 2018. Fecha de consulta: 27 de junio de 2018. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK448091/
Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82-5.
Goldstein A, Goldstein BG, Delavalle R. Pityriasis rosea - UpToDate. Fecha de consulta: 16 de abril de 2018. Disponible en: https://www.uptodate.com/contents/pityriasis-rosea.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collab. 2011. Fecha de consulta: 27 de junio de 2018. Disponible en: https://es.cochrane.org/sites/es.cochrane.org/files/public/uploads/Manual_Cochrane_510_reduit.pdf.
Moher D, Liberati A, Tetzlaff J, Altman DG. Academia and clinic preferred reporting items for systematic reviews and meta-analyses. Ann Intern Med. 2009;151:264-9.
Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 8 th edition. New York: McGrawHill Medical; 2012 Cap 42. Fecha de consulta: 27 de junio de 2018. Disponible en: https://accessmedicine.mhmedical.com/book.aspx?bookID=392
Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World J Clin Cases. 2017;5:203.
Chuh A, Zawar V, Sciallis G, Kempf W. A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatology Venereol. 2016;30:1670-81.
Singh S, Anurag, Tiwary N. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. Indian J Dermatology Venereol Leprol. 2016;82:505.
Ganguly S. A randomized, double-blind, placebocontrolled study of efficacy of oral acyclovir in the treatment of Pityriasis rosea. J Clin Diagnostic Res. 2014;8:1-4.
Rassai S, Feily A, Sina N, Abtahian S. Low dose of acyclovir may be an effective treatment against pityriasis rosea: A random investigator-blind clinical trial on 64 patients. J Eur Acad Dermatology Venereol. 2011;25:24-6.
Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82-5.
Amatya A, Rajouria EA, Karn DK. Comparative study of effectiveness of oral Acyclovir with oral erythromycin in the treatment of pityriasis rosea. Kathmandu Univ Med J. 2012;10:57-61.
Noormohammadpour P, Toosi S, Hosseinpour A, Hosseini M, Sayanjali S, Ehsani A, et al. The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea. Indian J Dermatol. 2010;55:246.
Sharma P, Yadav T, Gautam R, Taneja N, Satyanarayana L. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2000;42:241-4.
Ahmed N, Iftikhar N, Bashir U, Rizvi SDA, Sheikh ZI, Manzur A. Efficacy of clarithromycin in pityriasis rosea. J Coll Physicians Surg Pak. 2014;24:802-5.
Pandhi D, Singal A, Verma P, Sharma R. The efficacy of azithromycin in pityriasis rosea: A randomized, double-blind, placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2014;80:36.
Amer A. Azithromycin does not cure pityriasis rosea. Pediatrics. 2006;117:1702-5.
Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: A bilateral comparison study. J Am Acad Dermatol. 1995;33:996-9.
Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol. 1983;119:381-2.
Sonthalia S, Kumar A, Zawar V, Priya A, Yadav P, Srivastava S, et al. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. J Dermatolog Treat. 2018; 617-622.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
